Micha Abeles M.D.

Greater New York City Area, CT United States

Rheumatologist at the Center for Arthritis and Rheumatologic Disease

Medical / Health Care / Pharmaceuticals

Board certified in internal medicine and rheumatology and a former professor of medicine at the University of Connecticut (UConn) Health Center, Micha Abeles M.D. established his reputation as a groundbreaking researcher over almost four decades. Alongside overseeing numerous clinical trials leading the launch of medications such as Humira and Enbrel, Micha Abeles M.D. demonstrated the effectiveness of phosphodiesterase type 5 inhibitors in treating Buerger disease and methotrexate in treating rheumatoid arthritis. He was also amongst the authors on papers first describing eosinophilic fasciitis and fibromyalgia.